This association was significant for GSTO2 transcript levels measured from both the cerebellum and the temporal cortex; and in both the AD and control autopsy subjects, although the effect size estimates appeared to be bigger for the ADs and the cerebellum. The gene discussed is GSTO2; the disease is Alzheimer disease.